Knowledge graph · Cancer
Microsatellite Stable Rectal Carcinoma
molecular subtype
- Identifier
- CI-CAN-00008997
- Edges
- 3
- Neighbours
- 3 trials
- Drawn
- 3 of 3 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Microsatellite Stable Rectal Carcinoma studied in …STUDIED_INderived3 of 3 | ||||||||
| → studied in | NCT07735624Phase 2 · recruiting RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer · condition mapped ONTOLOGY_EXACT · 3 trials mapped (2 active) | — | — | Microsatellite Stable Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843434Phase 2 · recruiting A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 3 trials mapped (2 active) | |||||||